Colorcon

Colorcon designs, and provides technical support for, advanced coating systems, modified release technologies and functional excipients to pharma and nutritional supplement companies for solid oral dosage forms. It is a multinational company with operations throughout the world.

Headquarters
Colorcon Inc
275 Ruth Road
Harleysville
PA 19438
United States

Phone / Contact

T: +1 215 699 7733

Connect

Colorcon develops, supplies and provides technical support for formulated film-coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Its products and technologies are complemented by value-added services, supporting all phases of solid dose design, development, and manufacture.

The company employs 1200 people worldwide, at 11 manufacturing facilities and 21 technical service laboratories.

Colorcon was founded in 1961 and is a wholly owned subsidiary of privately owned BPSI Holdings LLC.

Articles by Colorcon

SMARTER MEDICINES TO SECURE PRODUCTS AND PROMOTE PATIENT ENGAGEMENT

Gary Pond looks at digital authentication and discusses how on-dose microtaggants can provide a high level of security in authenticating tablets and capsules in the fight against counterfeit products.

AN EASY PILL TO SWALLOW

Kelly Boyer and Ali Rajabi-Siahboomi explore the role of different tablet coating materials in improving the patient experience and adherence to prescription regimens.

Message from Colorcon CEO Martti Hedman

Martti Hedman, Chief Executive of Colorcon, has released a statement in which he confirmed that Colorcon is continuing its business activities, which had been categorised as essential and life sustaining by authorities around the world. He noted that Colorcon materials and coatings are used in some of the drugs that are being evaluated for use to treat COVID-19.

THE TRUSTED TABLET: A NEW LEVEL OF SUPPLY CHAIN SECURITY FROM MASS DIGITALISATION OF MEDICINES

Kelly Boyer, Trent Lund and Barry McDough describe a means of mass digitalising medicines to address the problem of illegal and unauthorised production of pharmaceutical products in a meaningful way.

Dr Elizabeth Shen

DR ELIZABETH SHEN, COLORCON

Elizabeth Shen talks taste-masking, from the positive impact on medication adherence, to technical approaches and technology selection, and regulatory considerations.

Top